Position in AZN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,262,679
-$211,737 QoQ
Shares Held
6,659
-10.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#620
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRANSCEND CAPITAL ADVISORS, LLC holds $69,576,548 across 11 Drug Manufacturers - General names. AZN ranks #8 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
262,453 | $33,725,210 | |
| 2 | JNJ |
Johnson & Johnson
|
43,125 | $10,952,456 | |
| 3 | LLY |
ELI LILLY & Co
|
6,902 | $8,278,466 | |
| 4 | ABBV |
AbbVie Inc.
|
29,656 | $7,462,635 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
55,185 | $3,179,759 | |
| 6 | AMGN |
Amgen Inc
|
4,077 | $1,476,363 | |
| 7 | NVS |
Novartis AG
|
8,348 | $1,308,298 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
6,659 | $1,262,679 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,262,679 | 6,659 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $1,474,416 | 7,476 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||